Artificial intelligence has moved from novelty to infrastructure. It recommends what we watch, helps people write and code, routes packages, summarizes research, and increasingly assists with decisions that used to require teams of specialists. The important shift is not that AI can talk. It is that AI systems are beginning to plan, use tools, check their own work, and carry a task across multiple steps.
That progression matters for biotechnology because drug discovery is not a single question. It is a chain of decisions: which target to pursue, which molecule to design, which assay to run, which safety signal to trust, and which clinical protocol will give patients the best chance of benefit. Agentic AI is designed for exactly that kind of connected work.
The Rise of Chatbots: How AI Began to Converse
Millions of people have already encountered AI through chatbots, the most famous of which is ChatGPT. The name itself—short for “Chat Generative Pre-trained Transformer”—might sound complex, but at its core, ChatGPT is a sophisticated computer program that can understand and respond to text in a remarkably human-like manner.
What makes ChatGPT impressive is its ability to generate coherent, context-aware responses. It achieves this by analyzing vast amounts of text data, learning patterns in human language, and predicting what words should come next in a sentence. This allows it to summarize information, translate languages, write stories, and even brainstorm business ideas.
What sets ChatGPT apart from earlier chatbots is its versatility. Traditional chatbots were rigid, following predefined scripts with little flexibility. ChatGPT, on the other hand, can engage in meaningful discussions on a wide range of topics. Whether you need help composing an email, solving a math problem, or crafting a poem, it can adapt to the task at hand.
Yet, despite its conversational abilities, the first generation of ChatGPT had its limitations. It doesn’t “think” in the way humans do. It generates responses based on patterns rather than true understanding, which brings us to the next evolution of AI—machines that can reason.
Beyond Chat: The Emergence of Reasoning AI
While chatbots are excellent at mimicking human conversation, they sometimes struggle when faced with complex, multi-step problems. That’s where reasoning AI comes in. These advanced systems go beyond simply predicting words—they analyze information, draw logical conclusions, and solve problems in ways that resemble human thinking.
Reasoning AI systems are designed to handle more intricate decisions. They still rely on learned patterns, but they can break a problem into steps, compare alternatives, use external tools, and explain why one path looks stronger than another. For a scientist, that changes AI from a writing assistant into something closer to an analytical partner.
Take the healthcare industry, for example. AI-driven diagnostic tools can analyze medical data, compare symptoms to clinical knowledge bases, and help clinicians consider possible diagnoses. In finance, AI can assess risks and flag unusual patterns. In education, reasoning AI can tailor lesson plans to fit a student’s learning style, creating a more personalized experience.
The ability to reason brings AI closer to true intelligence, but the next step in its evolution is even more profound: machines that can act on their own.
The Rise of Agent AI: Machines That Both Think and Act
Imagine an AI that doesn’t just answer questions or provide insights but can take real action on your behalf. These are known as agent AIs, systems designed to observe their environment, reason about what needs to be done, and execute tasks autonomously.
Unlike chatbots or reasoning AI, agent AI has the ability to interact with the world. Think of it as a digital personal assistant that not only reminds you of an upcoming trip but books the flight, arranges transportation, and checks you into your hotel. Or picture an AI-powered warehouse where robots don’t just move products but also optimize storage, repair themselves, and coordinate logistics with suppliers, all without human intervention.
Self-driving cars are another example of agent AI in action. These vehicles continuously analyze traffic conditions, make split-second decisions, and navigate roads independently, aiming for safety and efficiency. In the future, similar AI-driven systems could manage entire cities’ traffic flows, reducing congestion and optimizing transportation networks.
This shift towards autonomous AI marks a major turning point. We’re moving from AI as a tool that assists us to AI as a partner that can take initiative, solve problems, and operate in the world on its own.
AgentCures: Agent AI That Creates New Medicines
AgentCures is built around this agentic model for pharma. Instead of treating AI as a point solution for docking, writing, or trial simulation, the platform connects those capabilities into a research loop. The agent can design molecules, evaluate safety and developability, recommend experiments, update its plan when new data arrives, and draft the documents needed to explain the work.
Drug discovery is treated like code: every experiment, molecule, and document is structured, version-controlled, and iterative. AgentCures commits its work to Git, giving scientists a clear audit trail and a practical way to review, improve, and approve AI-generated research.
The goal is not to remove scientists from the process. It is to remove the avoidable waiting, copying, searching, and reformatting that slow science down. Humans set priorities and make judgment calls; the AI agent does the exhaustive work of exploring options, documenting decisions, and keeping the program moving.